Thin-layer liquid-based cervical cytology and PCR for detecting and typing human papillomavirus DNA in Flemish women

British Journal of Cancer

Volumn 88, Issue 4, 2003, Pages 560-566

  Depuydt, C E ^a   Vereecken, A J ^a   Salembier, G M ^a   Vanbrabant, A S ^a   Boels, L A ^a   Van Herck, E ^a   Arbyn, M ^b   Segers, K ^a   Bogers, J J ^a,c  

^a Laboratory for Clinical Pathology (Labo Lokeren Campus RIATOL)   (Belgium)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Belgium; Cervical cancer screening; Flanders; Human papillomavirus (HPV)

Indexed keywords

VIRUS DNA;

ADULT; AGE; ARTICLE; BELGIUM; CONTROLLED STUDY; DNA ISOLATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL ANALYSIS; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BELGIUM; CERVIX UTERI; CYTOLOGICAL TECHNIQUES; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS;

EID: 0037463233     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600756     Document Type: Article

References (39)

1. ALTS group (2000) Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomised trial. The atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesions triage study (ALTS) group. J Natl Cancer Inst 92: 397-402
2. Arbyn M, Bourgain C, Cuvelier C, Drijkoningen M, Van Marck E, Willocx F, WUCC (1999) The Flemish Cervical Cancer Screening Register: creation and first results. Acta Cytol 43: 708-709
3. Arbyn M, Van Oyen H (1999) Secondary Prevention of Cervical Cancer in Flanders: Facts and Proposition for a Structural Approch (in Dutch), WIV/EPISERIE no 20, p105. Brussels: Scientific Institute of Public Health.
4. Arbyn M, Van Oyen H (2000) Cervical cancer screening in Belgium. Eur J Cancer 36: 2191-2197
5. Arbyn M, Van Ranst M. (2002) Triage of women with atypical or low-grade cytological abnormalities of the cervix by HPV testing: systematic review and meta-analysis. Brussels: Scientific Institute of Public Health. IPH/EPI-Reports No. 2001-019.
6. Baay MFD, Tjalma WAA, Weyler J, Goovaerts G, Buytaert P, Van Marck EAE, Lardon F, Vermorken JB (2001) Human papillomavirus infection in the female population of Antwerp, Belgium: prevalence in healthy women, women with premalignant lesions and cervical cancer. Eur J Gynaec Oncol 22(3): 204-208.
7. Bauer HM, Ting Y, Greer CE, Chamber JC, Tashiro CJ, Chimera A, Reingold A, Manos MM (1991) Genital human papillomavirus infection in female university students as determined by a PCR based method. JAMA 265: 472-477
8. Berumen J, Casas L, Segura E, Amezcua JL, Garcia-Carranca A (1994) Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes. Int J Cancer 56: 640-645
9. Bosch FX, Lorincz A, Muñoz N, Meijer CJLM, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265
10. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST, Guillebaud J (1995) Human papillomavirus testing in primary cervical screening. Lancet 345: 1533-1536
11. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M (1994) Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 69: 167-171
12. Feoli-Fonseca JC, Oligny LL, Brochu P, Simard P, Falconi S, Yotov WV (2001) Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol 63(4): 284-292
13. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Shiffman MH, Scott DR, Apple RJ (2000) Improved amplification of genital human papillomaviruses. J Clin Microbiol 38(1): 357-361
14. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M (2000) Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92: 464-474
15. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manos MM (1994) Persistence of type-specific human papillomavirus infection among cytologically normal women. JID 169: 235-240
16. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1995) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 64, Human Papillomaviruses. Lyon (France): IARC.
17. Jenkins D, Sherlaw-Johnson C, Gallivan S (1996) Can papillomavirus testing be used to improve cervical cancer screening?. Int J Cancer 65: 768-773
18. Kim JJ, Wright TC, Goldie SJ (2002) Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 287: 2382-2390
19. Kiviat NB, Koutsky LA (1993) Specific human papillomavirus types as the causal agents of most cervical intraepithelial neoplasia: implications for current views and treatment J Natl Cancer Inst 85: 934-935
20. Kurman RJ, Schiffman MH, Lancaster WD, Reid R, Jenson AB, Temple GF, Lorincz AT (1988) Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am J Obstet Gynecol 159(2): 293-296
21. Kurman RJ, Solomon D. (1996) The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses. New York (NY): Springer-Verlag
22. Lörincz A (1992) Diagnosis of human papillomavirus infections by the new generation of molecular DNA assays. Clin Immunol News Lett 8: 123-130
23. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. (1989) Cancer Cells 7: Molecular Diagnostics of Human Cancer, pp. 209-214. Cold spring Harbor (NY): Cold Spring Harbor Laboratory Press.
24. Meijer CJ, van den Brule AJ, Snijders PJ, Helmerhorst T, Kenemans P, Walboomers JM (1992) Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening. IARC Sci Publ 119: 271-281
25. National Cancer Register (2000). Cancer in Belgium 1993-95. Oeuvre belge contre le Cancer/Belgisch Werk tegen Kanker, Brussels.
26. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Bezemer PD, Verheijen RH, Meijer CJ (2001) Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 358: 1782-1783
27. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94(2): 153-156
28. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GYF, Klein RS, Burk RD (1997) PCR detection of human papillomavirus: Comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35: 1304-1310
29. Riethmuller D, Gay C, Bertrand X, Bettinger D, Schaal JP, Carbillet JP, Lassabe C, Arveux P, Seilles E, Mougin C (1999) Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by hybrid capture II and polymerase chain reaction. Diagn Mol Pathol 8(3): 157-164
30. Schiffman MH, Bauer HM, Hoover RN (1993) Epidemiologic evidence showing that human papillomavirus infection causes most intraepethelial neoplasia. J Natl Cancer Inst 85: 958-964
31. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH (1995) MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 48: 257-262
32. Solomon D, Schiffman M, Tarone R (2001) Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93: 293-299
33. Stoler MH (2001) HPV testing is not useful for LSIL triage - but stay tuned. Adv Anat Pathol 8(3): 160-164
34. Torroella-Kouri M, Morsberger S, Carrillo A, Mohar A, Meneses A, Ibarra M, Daniel RW, Ghaffari AM, Solorza G, Shah KV (1998) HPV prevalence among Mexican women with neoplastic and normal cervixes. Gynecol Oncol 70: 115-120
35. van den Brule AJ, Meijer CJ, Bakels V, Kenemans P, Walboomers JM (1990) Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 28: 2739-2743
36. Vassilakos P, Griffin S, Megevand E, Campana A (1998) CytoRich liquid-based cervical cytology test: screening results in a routine cytopathology service. Acta Cytol 42: 198-202
37. Vassilakos P, Saurel J, Rondez R (1999) Direct-to-vial use of the AutoCyte PREP liquid-based preparation for cervical - vaginal specimens in three European laboratories. Acta Cytol 42: 65-68
38. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
39. Zielinski GD, Snijders PJF, Rozendaal L, Voorhorst FJ, Runsink AP, de Schiper FA, Meijer CJLM (2001) High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance. J Pathol 195: 300-306, doi:10.1054/bjoc.2001.1926